🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

19+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 19 of 19 recruiting trials for “anaplastic-oligodendroglioma

EARLY_Phase 1RecruitingNCT06333899

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

👨‍⚕️ Hamza Gorsi, MD, Children's Hospital of Michigan📍 18 sites📅 Started Aug 2025View details ↗
Phase 1, PHASE2RecruitingNCT05956821

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

👨‍⚕️ Heather McCrea, MD, University of Miami📍 1 site📅 Started Jun 2025View details ↗
Phase 2RecruitingNCT06161974

Study of Olutasidenib and Temozolomide in HGG

👨‍⚕️ Santosh Valvi, FRACP, MSc, Perth Children's Hospital📍 18 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT05843253

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

👨‍⚕️ Margot Lazow, MD, Nationwide Children's Hospital📍 21 sites📅 Started Aug 2024View details ↗
RecruitingNCT05839379

Targeted Pediatric High-Grade Glioma Therapy

👨‍⚕️ Maryam Fouladi, MD, Nationwide Children's Hospital📍 21 sites📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06264388

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

👨‍⚕️ Ashish Shah, MD, University of Miami📍 1 site📅 Started May 2024View details ↗
Phase 1RecruitingNCT05698524

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

👨‍⚕️ Nicole A Shonka, MD, University of Nebraska📍 1 site📅 Started Jun 2023View details ↗
Phase 1, PHASE2RecruitingNCT05278208

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

👨‍⚕️ Margot Lazow, MD, Nationwide Children's Hospital📍 4 sites📅 Started Nov 2022View details ↗
Phase 1, PHASE2RecruitingNCT05084430

Study of Pembrolizumab and M032 (NSC 733972)

👨‍⚕️ James Markert, MD, The University of Alabama at Birmingham📍 1 site📅 Started Feb 2022View details ↗
NARecruitingNCT05057702

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

👨‍⚕️ Sabine Mueller, MD, PhD, MAS, University of California, San Francisco📍 8 sites📅 Started Feb 2022View details ↗
EARLY_Phase 1RecruitingNCT04135807

Implantable Microdevice In Primary Brain Tumors

👨‍⚕️ Pier Paolo Peruzzi, MD, PhD, Brigham and Women's Hospital📍 1 site📅 Started Mar 2020View details ↗
Phase 2RecruitingNCT04623931

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

👨‍⚕️ Debra N Yeboa, M.D. Anderson Cancer Center📍 1 site📅 Started Jan 2020View details ↗
Phase 1RecruitingNCT03911388

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

👨‍⚕️ Gregory Friedman, MD, M.D. Anderson Cancer Center📍 3 sites📅 Started Sep 2019View details ↗
Phase 1RecruitingNCT03750513

LET Optimized IMPT in Treating Pediatric Patients With Ependymoma

👨‍⚕️ David R Grosshans, M.D. Anderson Cancer Center📍 2 sites📅 Started Apr 2019View details ↗
Phase 1RecruitingNCT03896568

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

👨‍⚕️ Frederick F Lang, M.D. Anderson Cancer Center📍 1 site📅 Started Feb 2019View details ↗
Phase 1, PHASE2RecruitingNCT03603405

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

👨‍⚕️ David S. Baskin, MD, Houston Methodist Neurological Institute📍 1 site📅 Started Feb 2018View details ↗
RecruitingNCT04780009

Loupe-Based Intraoperative Fluorescence Imaging

👨‍⚕️ Guoqiang Yu, PhD, University of Kentucky📍 1 site📅 Started Nov 2017View details ↗
Phase 2RecruitingNCT02800486

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

👨‍⚕️ John Boockvar, MD, Northwell Health📍 1 site📅 Started May 2016View details ↗
Phase 1, PHASE2RecruitingNCT01269853

Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

👨‍⚕️ John Boockvar, MD, Feinstein Institute for Medical Research📍 1 site📅 Started Oct 2010View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →